Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | HCRTR1 | O43613 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | GRM5 | P41594 | 1/20 | 0.39 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1838148 | 0.98 | ALDH1A1 (0.54) | ALDH1A1L3MBTL1MAPTNPSR1GLA | |
| SCHEMBL30707397 | 0.86 | ALDH1A1 (0.47) | ALDH1A1L3MBTL1MAPTNPSR1GLA | |
| SCHEMBL1833246 | 0.86 | ALDH1A1 (0.47) | ALDH1A1L3MBTL1MAPTNPSR1GLA | |
| SCHEMBL9181053 | 0.86 | ALDH1A1 (0.47) | ALDH1A1L3MBTL1MAPTNPSR1GLA | |
| SCHEMBL2154421 | 0.81 | ALDH1A1 (0.50) | ALDH1A1L3MBTL1MAPTNPSR1GLA | |
| SCHEMBL16394145 | 0.81 | ALDH1A1 (0.50) | ALDH1A1L3MBTL1MAPTNPSR1GLA | |
| SCHEMBL2154483 | 0.81 | ALDH1A1 (0.50) | ALDH1A1L3MBTL1MAPTNPSR1GLA | |
| SCHEMBL1840409 | 0.81 | CYP1A2 (0.46) | ALDH1A1L3MBTL1MAPTNPSR1CYP1A2 | |
| SCHEMBL31413828 | 0.79 | ALDH1A1 (0.48) | ALDH1A1L3MBTL1MAPTNPSR1GLA | |
| SCHEMBL9187416 | 0.79 | ALDH1A1 (0.44) | ALDH1A1L3MBTL1MAPTNPSR1GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3466988-B1 | OLIGOMERIZING CATALYST AND METHOD FOR PREPARING ETHYLENE OLIGOMER USING SAME | SK INNOVATION CO LTD (KR) | 2023-11-29 | — | — | EP | disclosed |
| US-11235315-B2 | Oligomerization catalyst and method for preparing ethylene oligomer using same | SK INNOVATION CO., LTD. (KR) | 2022-02-01 | — | — | US | disclosed |
| US-20190308178-A1 | Oligomerization Catalyst and Method for Preparing Ethylene Oligomer Using Same | SK INNOVATION CO, LTD. (KR) | 2019-10-10 | — | — | US | disclosed |
| EP-3466988-A1 | OLIGOMERIZING CATALYST AND METHOD FOR PREPARING ETHYLENE OLIGOMER USING SAME | SK Innovation Co., Ltd. (KR) | 2019-04-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11235315-B2 | Oligomerization catalyst and method for preparing ethylene oligomer using same | AP1M1, NOD2, NOD1 | ALDH1A1 3963/4885L3MBTL1 4508/4885MAPT 1491/4885 |
| US-20190308178-A1 | Oligomerization Catalyst and Method for Preparing Ethylene Oligomer Using Same | AP1M1, NOD2, NOD1 | ALDH1A1 4067/4885L3MBTL1 4438/4885MAPT 1484/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.